Five-year survival rate and factors affecting the survival of hemodialysis patients

authors:

avatar Danial Habibi , avatar Sarkav Usefi , avatar Azam Moslemi ORCID , *

Koomesh: Vol.21, issue 2; 271-275
published online: May 02, 2019
article type: Research Article
received: December 01, 2017
accepted: October 02, 2018

how to cite: Habibi D, Usefi S, Moslemi A. Five-year survival rate and factors affecting the survival of hemodialysis patients. koomesh. 2019;21(2):e153067. 

Abstract

Introduction: Survival rate is important in chronic kidney disease patients due to their dependence on hemodialysis. Therefore, the aim of this study was to evaluate the survival rate of five- years and factors affecting the survival of hemodialysis patients. Materials and Methods: This historical cohort study was performed in 60 hemodialysis patients admitted to Kamyaran Sina Hospital (Iran). Statistical analysis was done using the Kaplan-Meier curve and compared by the Log-Rank test. Correspondingly, to determine the most important factors affecting the prognosis of survival of patients, we used Cox regression model. Results: The mean and median survival was 31.4 months and 34 months respectively. The survival rate of 1 year, 2 years, 3 years, 4 years and 5 years for patients were 84%, 60%, 49%, 25% and 10%, respectively. The mean albumin was significant based on the Cox regression. Conclusion: The results of Cox regression indicated that the mean of albumin was the most important factor and also had a protective effect on hemodialysis patients. Remarkably, the survival rates of these patients will be increased if the mean of albumin has an increase.

References

  • 1.

    Teixeira FI, Lopes ML, Silva GA, Santos RF. Survival of hemodialysis patients at a university hospital. J Bras Nefrol 2015; 37: 64-71.

  • 2.

    Sharma S, Sarnak MJ. Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality. Nature Rev Nephrol 2017; 13: 447-448.

  • 3.

    Mousavi SSB, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl 2014; 25: 697-702.

  • 4.

    Control CfD, Prevention. Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007; 56: 161-165.

  • 5.

    Asgari MR, Motlagh NH, Soleimani M, Ghorbani R. Effect of lidocaine spray on the pain intensity during insertion of vascular needles in hemodialysis patients. Koomesh 2013; 14. (Persian).

  • 6.

    Sohrabi Z, Salehi M, Ekramzade M, Sagheb MM, Ayatollahi M, Hassanzade J. Effect of selenium supplement on quality of life in hemodialysis patients. Koomesh 2015; 16. (Persian).

  • 7.

    Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull 2005; 73: 35-55.

  • 8.

    Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol 2006; 1: 710-717.

  • 9.

    Singapuri MS, Lea JP. Management of hypertension in the end-stage renal disease patient. JCOM 2010; 17.

  • 10.

    Jablonski A. The multidimensional characteristics of symptoms reported by patients on hemodialysis. Nephrol Nurs J 2007; 34: 29-37.

  • 11.

    Rambod H. Chronic renal failure. Sci Dial Patient Nurs Phys 2008; 3: 1-2.

  • 12.

    Abede M, Aghaee N, Gholame F. Evaluation of hemodialysis adequacy on patients undergoing hemodialysis in Razi Hospital in Rasht. J Med Facul Mazanderan Univ Med Sci 2010; 23: 20-27. (Persian).

  • 13.

    Ghods AJ, Savaj S. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006; 1: 1136-1145.

  • 14.

    Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, et al. Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis 2010; 55: S1-420.

  • 15.

    Raiesifar A, Torabpour M, Mohsenizad P. Causes of chronic renal failure in hemodialysis patients of Abadan. J Crit Care Nurs 2010; 2: 11-12. (Persian).

  • 16.

    Habibi D, Rafiei M, Chehrei A, Shayan Z, Tafaqodi S. Comparison of survival models for analyzing prognostic factors in gastric cancer patients. Asian Pac J Cancer Prev 2018; 19: 749-753.

  • 17.

    Montaseri M, Charati JY, Espahbodi F, Mousavi SJ. Five-year survival rate in hemodialysis patients attending Sari Imam Khomeini hospital. J Mazandaran Univ Med Sci 2013; 23: 78-85. (Persian).

  • 18.

    Shabankhani B, Kazemnejad A, Zaeri F, Espahbodi F, Ahmadi MH, Mirkazemi R. Survival factors in patients with end-stage renal disease in Mazandaran province, Iran. Iran J Kidney Dis 2016; 10: 79-84.

  • 19.

    Yeates A, Hawley C, Mundy J, Pinto N, Haluska B, Shah P. Treatment outcomes for ischemic heart disease in dialysis-dependent patients. Asian Cardiovasc Thorac Ann 2012; 20: 281-291.

  • 20.

    Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 2002; 13: 1889-1893.

  • 21.

    Argyropoulos C, Chang CC, Plantinga L, Fink N, Powe N, Unruh M. Considerations in the statistical analysis of hemodialysis patient survival. J Am Soc Nephrol 2009; 20: 2034-2043.